ReviewFrontiers in bioengineering and biotechnology2025
3D-printed artificial bone scaffolds: the design of materials, the incorporation of bioactive substances, and the integration of vascularized tissue flaps.
Review in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Combining Fluid Dynamics and Biological Experiments to Explore the More Suitable Porosity for Bone Inducing Porous Tantalum Scaffolds.Orthopaedic surgery · 2026Article
- Bone Organoids as Advanced Models for Osteoporosis: Development, Application, and Future Prospects.International journal of molecular sciences · 2026Review
- Emerging Biomaterials for Maxillary Sinus Augmentation: From In Vitro Insights to In Vivo Clinical Translation.Materials (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With the advancements in tissue engineering, materials science, microsurgery, and the maturation of 3D printing technology, 3D-printed artificial bone scaffolds have provided an innovative strategy that integrates structural bionics and functional synergy for the treatment of large-segment bone defects. Compared with conventional bone grafting, this technology not only precisely reconstructs anatomical geometry and promotes cell migration through porous design, but also, via surface modification, enables accurate loading and controlled release of multiple bioactive factors, thereby actively regulating osteogenesis and angiogenesis, enhancing regeneration efficiency, and overcoming the traditional scaffold limitation of "mechanical support only, lack of biological guidance." Nevertheless, repair of large-segment defects still faces challenges such as early ischemia, restricted nutrient diffusion, and slow callus formation. To address this bottleneck, the present study summarizes a "vascularization-osteogenesis integration" scaffold design paradigm that combines 3D printing with vascularized bone substitutes, realizing a "scaffold plus vascular-pedicled flap" co-implantation strategy; the vascular network of the flap traverses the entire scaffold, establishing a co-culture microenvironment of endothelial cells and mesenchymal stem cells and maximizing osteogenic and angiogenic efficiency. This review systematically analyzes the biomaterial properties of various 3D-printed bone scaffolds, strategies for loading bioactive factors, and cutting-edge progress in pedicled flap transplantation for bone and vessel regeneration, highlighting their distinctive advantages in vascularization and bioactivity modulation over traditional bone grafting, aiming to promote a paradigm shift from "structural replacement" to "biological function reconstruction" and provide both theoretical innovation and practical guidance for accelerating clinical translation of bone tissue engineering.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.